WBC
RPRX icon

Westpac Banking Corp’s Royalty Pharma RPRX Stock Holding History

Westpac Banking Corp’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,060
Closed -$64.1K – 482
2025
Q1 		$64.1K Hold
2,060
– – ﹤0.01% 429
2024
Q4 		$52.6K Buy
+2,060
New +$54.6K ﹤0.01% 454
2023
Q4 		– Sell
-2,891
Closed -$78.5K – 508
2023
Q3 		$78.5K Buy
+2,891
New +$85.9K 0.01% 452
2023
Q2 		– Sell
-26,612
Closed -$959K – 725
2023
Q1 		$959K Hold
26,612
– – 0.01% 652
2022
Q4 		$1.05M Hold
26,612
– – 0.02% 611
2022
Q3 		$1.07M Buy
26,612
+9,320
+54% +$398K 0.02% 611
2022
Q2 		$727K Sell
17,292
-1,471
-8% -$60.3K 0.01% 712
2022
Q1 		$731K Sell
18,763
-10,719
-36% -$421K 0.01% 735
2021
Q4 		$1.17M Sell
29,482
-252
-0.8% -$9.79K 0.01% 667
2021
Q3 		$1.07M Buy
29,734
+10,242
+53% +$398K 0.01% 713
2021
Q2 		$799K Buy
+19,492
New +$829K 0.01% 782
2021
Q1 		– Sell
-17,292
Closed -$865K – 839
2020
Q4 		$865K Buy
+17,292
New +$734K 0.01% 752

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $2.93B AUM 37.21% 1-Year Est. Return

Westpac Banking Corp's RPRX Position: Q2 2025 in Review

Westpac Banking Corp sold out of Royalty Pharma (RPRX) in Q2 2025, closing a stake of 2,060 shares — an estimated $64.1K sold.

Westpac Banking Corp first reported a position in RPRX in Q4 2020 and held it in 12 quarters. The position peaked at $1.17M in Q4 2021. 454 funds tracked by Wall St. Rank hold RPRX as of Q2 2025.

  • Westpac Banking Corp reported no remaining Royalty Pharma position as of Q2 2025 after selling out during the quarter.
  • Westpac Banking Corp sold 2,060 Royalty Pharma shares in Q2 2025, an estimated $64.1K.
  • Westpac Banking Corp first reported a position in Royalty Pharma in Q4 2020 and held it in 12 quarters.
  • Westpac Banking Corp's Royalty Pharma position peaked at $1.17M in Q4 2021.
  • 454 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2025.

Based on Westpac Banking Corp's 13F filing for Q2 2025, filed 11 Aug 2025.